For reprint rights or to purchase a copy of your Daily Journal photo, email Jeremy_Ellis@dailyjournal.com for prices or call 213-229-5424.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Corporate

Nov. 8, 2006

Biotech, Casino Deals Help Make It a Safe Bet That 2006 Will Be a Record Setter

DEALS - Rick Kennedy - Biotech again led the way last week, as pharmaceutical giant Merck placed a $1.1 billion bet that the gene technology of San Francisco-based Sirna Therapeutics will develop into lifesaving and lucrative treatments.

Biotech again led the way last week, as pharmaceutical giant Merck placed a $1.1 billion bet that the gene technology of San Francisco-based Sirna Therapeutics will develop into lifesaving and lucrative treatments.
      Anybody who drives a car would figure that an even better bet would be oil-exploration company Seitel, logic that didn't escape San Francisco investment outfit ValueAct Capital, which announced a $790 million deal to acquire the...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.